Anika Therapeutics Inc. Common Stock ANIK
i
Market dataready · fetched 2026-11-11T15:39:19.074Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-12-18
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T15:38:38.207468399Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-11T15:39:18.402745+00:00
Anika Therapeutics Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 21.15 | 123.7% | 57.7% | |||
| 25Δ | ||||||
| 30Δ | 14.96 | 43.8% | 11.5% | |||
| 35Δ | 14.65 | 47.7% | 10.8% | 12.90 | 85.0% | 14.2% |
| 40Δ | 14.35 | 51.7% | 10.0% | 13.39 | 83.9% | 12.9% |
| 45Δ | 14.04 | 55.6% | 9.3% | 13.89 | 82.7% | 11.5% |
| 50Δ | 13.73 | 59.5% | 8.6% | 14.39 | 81.6% | 10.2% |
| 55Δ | 13.43 | 63.4% | 7.8% | 14.89 | 80.4% | 8.8% |
| 60Δ | 13.12 | 67.4% | 7.1% | 15.38 | 79.3% | 7.5% |
| 65Δ | 12.82 | 71.3% | 6.4% | 15.88 | 78.1% | 6.1% |
| 70Δ | 12.51 | 75.2% | 5.6% | 16.38 | 77.0% | 4.7% |
| 75Δ | 12.06 | 71.2% | 4.7% | 16.87 | 75.8% | 3.4% |
| 80Δ | 11.61 | 66.9% | 3.7% | 17.37 | 74.7% | 2.0% |
20Δ
- Pseudo strike
- 21.15
- IV
- 123.7%
- B/E move
- 57.7%
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- 14.96
- IV
- 43.8%
- B/E move
- 11.5%
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 14.65
- IV
- 47.7%
- B/E move
- 10.8%
- Pseudo strike
- 12.90
- IV
- 85.0%
- B/E move
- 14.2%
40Δ
- Pseudo strike
- 14.35
- IV
- 51.7%
- B/E move
- 10.0%
- Pseudo strike
- 13.39
- IV
- 83.9%
- B/E move
- 12.9%
45Δ
- Pseudo strike
- 14.04
- IV
- 55.6%
- B/E move
- 9.3%
- Pseudo strike
- 13.89
- IV
- 82.7%
- B/E move
- 11.5%
50Δ
- Pseudo strike
- 13.73
- IV
- 59.5%
- B/E move
- 8.6%
- Pseudo strike
- 14.39
- IV
- 81.6%
- B/E move
- 10.2%
55Δ
- Pseudo strike
- 13.43
- IV
- 63.4%
- B/E move
- 7.8%
- Pseudo strike
- 14.89
- IV
- 80.4%
- B/E move
- 8.8%
60Δ
- Pseudo strike
- 13.12
- IV
- 67.4%
- B/E move
- 7.1%
- Pseudo strike
- 15.38
- IV
- 79.3%
- B/E move
- 7.5%
65Δ
- Pseudo strike
- 12.82
- IV
- 71.3%
- B/E move
- 6.4%
- Pseudo strike
- 15.88
- IV
- 78.1%
- B/E move
- 6.1%
70Δ
- Pseudo strike
- 12.51
- IV
- 75.2%
- B/E move
- 5.6%
- Pseudo strike
- 16.38
- IV
- 77.0%
- B/E move
- 4.7%
75Δ
- Pseudo strike
- 12.06
- IV
- 71.2%
- B/E move
- 4.7%
- Pseudo strike
- 16.87
- IV
- 75.8%
- B/E move
- 3.4%
80Δ
- Pseudo strike
- 11.61
- IV
- 66.9%
- B/E move
- 3.7%
- Pseudo strike
- 17.37
- IV
- 74.7%
- B/E move
- 2.0%
Options history
Table
| Date | IV (%) |
|---|---|
| 70.83% | |
| 61.16% | |
| 95.61% | |
| 67.81% | |
| 81.02% | |
| 118.31% | |
| 40.81% | |
| 47.89% | |
| 49.21% | |
| 50.08% | |
| 44.85% | |
| 50.23% | |
| 47.08% | |
| 50.79% | |
| 49.66% | |
| 65.03% | |
| 58.50% | |
| 63.22% | |
| 49.87% | |
| 59.29% | |
| 61.41% | |
| 49.09% | |
| 76.59% | |
| 52.78% | |
| 54.82% | |
| 46.20% | |
| 60.59% | |
| 48.23% | |
| 49.81% | |
| 58.59% | |
| 62.20% | |
| 60.15% | |
| 55.92% | |
| 60.80% |
Drug Manufacturers - Specialty & Generic
ANIP
ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets brand-name and generic prescription pharmaceuticals in the United States and…
More →AQST
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and marketing various products to address unmet medical needs in the United States and…
More →BCRX
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.
More →BHC
Bausch Health Companies Inc. develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter (OTC) products primarily in the therapeutic areas of…
More →BIOA
Description unavailable
More →CGC
Canopy Growth Corporation is engaged in the production, distribution and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the…
More →